Capsule-based Inhalers Market
Capsule-based Inhalers Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Capsule-based Inhalers Market Size and Growth
The Capsule-based Inhalers market is experiencing significant growth, driven by increasing respiratory diseases and demand for efficient drug delivery methods. The market size is projected to reach approximately $2.5 billion by 2028, with a robust CAGR of around 9% due to advancements in inhalation technology and rising healthcare awareness. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Hovione
◍ Iconovo AB
◍ Inbrija
◍ Utibron Neohaler (Novartis AG)
◍ Zibo Laixu Medical Equipment
The capsule-based inhalers market features companies like Hovione, Iconovo AB, Inbrija, Novartis AG (Utibron Neohaler), and Zibo Laixu Medical Equipment. They innovate in product development, enhance delivery systems, and expand therapeutic applications, driving market growth through differentiation and accessibility. Revenue figures include:
- Novartis AG: $51 billion (2022)
- Hovione: $252 million (2021)
Request Sample Report
Market Segmentation
By Application
Asthma
COPD (Chronic Obstructive Pulmonary Disease)
By Product
Request Sample Report
Gelatin Capsules
Hypromellose Capsules
Market Growth
Request Sample Report
$ X Billion USD
